Loading…
Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis
Epithelial-mesenchymal transition (EMT) plays a pivotal event in the development of pulmonary fibrosis. We have previously reported that methotrexate (MTX)-induced alveolar epithelial cell injury followed by pulmonary fibrosis as a result of the recruitment and proliferation of myofibroblasts. Howev...
Saved in:
Published in: | Journal of toxicological sciences 2014/04/01, Vol.39(2), pp.319-330 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313 |
---|---|
cites | cdi_FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313 |
container_end_page | 330 |
container_issue | 2 |
container_start_page | 319 |
container_title | Journal of toxicological sciences |
container_volume | 39 |
creator | Ohbayashi, Masayuki Kubota, Satoshi Kawase, Aya Kohyama, Noriko Kobayashi, Yasuna Yamamoto, Toshinori |
description | Epithelial-mesenchymal transition (EMT) plays a pivotal event in the development of pulmonary fibrosis. We have previously reported that methotrexate (MTX)-induced alveolar epithelial cell injury followed by pulmonary fibrosis as a result of the recruitment and proliferation of myofibroblasts. However, there is no data concerning whether EMT occurs in MTX-induced pulmonary fibrosis. In the present study, therefore, we investigated the expression of EMT markers such as E-cadherin, α-SMA, and vimentin by immunofluorescence analysis in mouse lung tissues after administration of MTX. We found that vimentin and α-SMA-positive cells of the MTX-induced pulmonary fibrosis were increased; on the other hand, E-cadherin was decreased, indicating that epithelial cells act as the main source of mesenchymal expansion. These results exhibited the down-regulation of E-cadherin expression and the up-regulation of α-smooth muscle actin (α-SMA) in primary mouse alveolar epithelial cells (MAECs) and A549 cell lines. Additionally, MTX-induced A549 cells exhibited an EMT-like phenotype accompanied by the elevation of the expression of interleukin-6 (IL-6) and transforming growth factor (TGF)-β1, as well as an enhancement of migration. All of these findings suggest that MTX-induced pulmonary fibrosis occurs via EMT. |
doi_str_mv | 10.2131/jts.39.319 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1512807316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3266892261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313</originalsourceid><addsrcrecordid>eNo9kE9r2zAYh8XoWNNsl36AYeit4FTSG9vSYYcRujUQ6GU77SBk61WjYMuZJIfm208jf04C8fC8Px5C7hldcAbsaZfiAuQCmPxAZkwIWoIU8obMKAhRMqjoLbmLcUcpb2i1_ERu-bJe1g1bzsiftT-M_QEH9KkYbYF7l7bYO92XA0b03fY46L5IQfvokht94XwxYNqOKeC7Tlg6b6YOTbGf-mH0OhwL69owRhc_k49W9xG_nN85-f3j-dfqpdy8_lyvvm_KrpI0lbLNWwQ1gBUabhlYY7SGquHW1hW2sq2Z0A1vGacCGuBGMqwM1GA5AjCYk4eTdx_GvxPGpHbjFHw-qVjFuKANsDpTjyeqy-NiQKv2wQ15r2JU_e-ockcFUuWOGf56Vk7tgOaKXsJl4NsJ2MWk3_AK6JBc1-PFxc_C63-31UGhh3-aSYZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512807316</pqid></control><display><type>article</type><title>Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis</title><source>Free Full-Text Journals in Chemistry</source><creator>Ohbayashi, Masayuki ; Kubota, Satoshi ; Kawase, Aya ; Kohyama, Noriko ; Kobayashi, Yasuna ; Yamamoto, Toshinori</creator><creatorcontrib>Ohbayashi, Masayuki ; Kubota, Satoshi ; Kawase, Aya ; Kohyama, Noriko ; Kobayashi, Yasuna ; Yamamoto, Toshinori</creatorcontrib><description>Epithelial-mesenchymal transition (EMT) plays a pivotal event in the development of pulmonary fibrosis. We have previously reported that methotrexate (MTX)-induced alveolar epithelial cell injury followed by pulmonary fibrosis as a result of the recruitment and proliferation of myofibroblasts. However, there is no data concerning whether EMT occurs in MTX-induced pulmonary fibrosis. In the present study, therefore, we investigated the expression of EMT markers such as E-cadherin, α-SMA, and vimentin by immunofluorescence analysis in mouse lung tissues after administration of MTX. We found that vimentin and α-SMA-positive cells of the MTX-induced pulmonary fibrosis were increased; on the other hand, E-cadherin was decreased, indicating that epithelial cells act as the main source of mesenchymal expansion. These results exhibited the down-regulation of E-cadherin expression and the up-regulation of α-smooth muscle actin (α-SMA) in primary mouse alveolar epithelial cells (MAECs) and A549 cell lines. Additionally, MTX-induced A549 cells exhibited an EMT-like phenotype accompanied by the elevation of the expression of interleukin-6 (IL-6) and transforming growth factor (TGF)-β1, as well as an enhancement of migration. All of these findings suggest that MTX-induced pulmonary fibrosis occurs via EMT.</description><identifier>ISSN: 0388-1350</identifier><identifier>EISSN: 1880-3989</identifier><identifier>DOI: 10.2131/jts.39.319</identifier><identifier>PMID: 24646714</identifier><language>eng</language><publisher>Japan: The Japanese Society of Toxicology</publisher><subject>Actins - metabolism ; Alveolar epithelial cell ; Animals ; Cadherins - metabolism ; Cell Proliferation - drug effects ; Down-Regulation ; Epithelial Cells - drug effects ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Epithelial mesenchymal transition ; Epithelial-Mesenchymal Transition - drug effects ; Epithelial-Mesenchymal Transition - genetics ; Humans ; Interleukin-6 - metabolism ; Methotrexate ; Methotrexate - adverse effects ; Mice ; Myofibroblasts - cytology ; Myofibroblasts - drug effects ; Myofibroblasts - pathology ; Pulmonary Alveoli - cytology ; Pulmonary Fibrosis - genetics ; Pulmonary Fibrosis - physiopathology ; Pulmonary toxicity ; Transforming Growth Factor beta1 - metabolism ; Tumor Cells, Cultured ; Up-Regulation ; Vimentin - metabolism</subject><ispartof>The Journal of Toxicological Sciences, 2014/04/01, Vol.39(2), pp.319-330</ispartof><rights>2014 The Japanese Society of Toxicology</rights><rights>Copyright Japan Science and Technology Agency 2014</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313</citedby><cites>FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24646714$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohbayashi, Masayuki</creatorcontrib><creatorcontrib>Kubota, Satoshi</creatorcontrib><creatorcontrib>Kawase, Aya</creatorcontrib><creatorcontrib>Kohyama, Noriko</creatorcontrib><creatorcontrib>Kobayashi, Yasuna</creatorcontrib><creatorcontrib>Yamamoto, Toshinori</creatorcontrib><title>Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis</title><title>Journal of toxicological sciences</title><addtitle>J Toxicol Sci</addtitle><description>Epithelial-mesenchymal transition (EMT) plays a pivotal event in the development of pulmonary fibrosis. We have previously reported that methotrexate (MTX)-induced alveolar epithelial cell injury followed by pulmonary fibrosis as a result of the recruitment and proliferation of myofibroblasts. However, there is no data concerning whether EMT occurs in MTX-induced pulmonary fibrosis. In the present study, therefore, we investigated the expression of EMT markers such as E-cadherin, α-SMA, and vimentin by immunofluorescence analysis in mouse lung tissues after administration of MTX. We found that vimentin and α-SMA-positive cells of the MTX-induced pulmonary fibrosis were increased; on the other hand, E-cadherin was decreased, indicating that epithelial cells act as the main source of mesenchymal expansion. These results exhibited the down-regulation of E-cadherin expression and the up-regulation of α-smooth muscle actin (α-SMA) in primary mouse alveolar epithelial cells (MAECs) and A549 cell lines. Additionally, MTX-induced A549 cells exhibited an EMT-like phenotype accompanied by the elevation of the expression of interleukin-6 (IL-6) and transforming growth factor (TGF)-β1, as well as an enhancement of migration. All of these findings suggest that MTX-induced pulmonary fibrosis occurs via EMT.</description><subject>Actins - metabolism</subject><subject>Alveolar epithelial cell</subject><subject>Animals</subject><subject>Cadherins - metabolism</subject><subject>Cell Proliferation - drug effects</subject><subject>Down-Regulation</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Epithelial mesenchymal transition</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Humans</subject><subject>Interleukin-6 - metabolism</subject><subject>Methotrexate</subject><subject>Methotrexate - adverse effects</subject><subject>Mice</subject><subject>Myofibroblasts - cytology</subject><subject>Myofibroblasts - drug effects</subject><subject>Myofibroblasts - pathology</subject><subject>Pulmonary Alveoli - cytology</subject><subject>Pulmonary Fibrosis - genetics</subject><subject>Pulmonary Fibrosis - physiopathology</subject><subject>Pulmonary toxicity</subject><subject>Transforming Growth Factor beta1 - metabolism</subject><subject>Tumor Cells, Cultured</subject><subject>Up-Regulation</subject><subject>Vimentin - metabolism</subject><issn>0388-1350</issn><issn>1880-3989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kE9r2zAYh8XoWNNsl36AYeit4FTSG9vSYYcRujUQ6GU77SBk61WjYMuZJIfm208jf04C8fC8Px5C7hldcAbsaZfiAuQCmPxAZkwIWoIU8obMKAhRMqjoLbmLcUcpb2i1_ERu-bJe1g1bzsiftT-M_QEH9KkYbYF7l7bYO92XA0b03fY46L5IQfvokht94XwxYNqOKeC7Tlg6b6YOTbGf-mH0OhwL69owRhc_k49W9xG_nN85-f3j-dfqpdy8_lyvvm_KrpI0lbLNWwQ1gBUabhlYY7SGquHW1hW2sq2Z0A1vGacCGuBGMqwM1GA5AjCYk4eTdx_GvxPGpHbjFHw-qVjFuKANsDpTjyeqy-NiQKv2wQ15r2JU_e-ockcFUuWOGf56Vk7tgOaKXsJl4NsJ2MWk3_AK6JBc1-PFxc_C63-31UGhh3-aSYZA</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Ohbayashi, Masayuki</creator><creator>Kubota, Satoshi</creator><creator>Kawase, Aya</creator><creator>Kohyama, Noriko</creator><creator>Kobayashi, Yasuna</creator><creator>Yamamoto, Toshinori</creator><general>The Japanese Society of Toxicology</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope></search><sort><creationdate>20140401</creationdate><title>Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis</title><author>Ohbayashi, Masayuki ; Kubota, Satoshi ; Kawase, Aya ; Kohyama, Noriko ; Kobayashi, Yasuna ; Yamamoto, Toshinori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Actins - metabolism</topic><topic>Alveolar epithelial cell</topic><topic>Animals</topic><topic>Cadherins - metabolism</topic><topic>Cell Proliferation - drug effects</topic><topic>Down-Regulation</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Epithelial mesenchymal transition</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Humans</topic><topic>Interleukin-6 - metabolism</topic><topic>Methotrexate</topic><topic>Methotrexate - adverse effects</topic><topic>Mice</topic><topic>Myofibroblasts - cytology</topic><topic>Myofibroblasts - drug effects</topic><topic>Myofibroblasts - pathology</topic><topic>Pulmonary Alveoli - cytology</topic><topic>Pulmonary Fibrosis - genetics</topic><topic>Pulmonary Fibrosis - physiopathology</topic><topic>Pulmonary toxicity</topic><topic>Transforming Growth Factor beta1 - metabolism</topic><topic>Tumor Cells, Cultured</topic><topic>Up-Regulation</topic><topic>Vimentin - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Ohbayashi, Masayuki</creatorcontrib><creatorcontrib>Kubota, Satoshi</creatorcontrib><creatorcontrib>Kawase, Aya</creatorcontrib><creatorcontrib>Kohyama, Noriko</creatorcontrib><creatorcontrib>Kobayashi, Yasuna</creatorcontrib><creatorcontrib>Yamamoto, Toshinori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><jtitle>Journal of toxicological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohbayashi, Masayuki</au><au>Kubota, Satoshi</au><au>Kawase, Aya</au><au>Kohyama, Noriko</au><au>Kobayashi, Yasuna</au><au>Yamamoto, Toshinori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis</atitle><jtitle>Journal of toxicological sciences</jtitle><addtitle>J Toxicol Sci</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>39</volume><issue>2</issue><spage>319</spage><epage>330</epage><pages>319-330</pages><issn>0388-1350</issn><eissn>1880-3989</eissn><abstract>Epithelial-mesenchymal transition (EMT) plays a pivotal event in the development of pulmonary fibrosis. We have previously reported that methotrexate (MTX)-induced alveolar epithelial cell injury followed by pulmonary fibrosis as a result of the recruitment and proliferation of myofibroblasts. However, there is no data concerning whether EMT occurs in MTX-induced pulmonary fibrosis. In the present study, therefore, we investigated the expression of EMT markers such as E-cadherin, α-SMA, and vimentin by immunofluorescence analysis in mouse lung tissues after administration of MTX. We found that vimentin and α-SMA-positive cells of the MTX-induced pulmonary fibrosis were increased; on the other hand, E-cadherin was decreased, indicating that epithelial cells act as the main source of mesenchymal expansion. These results exhibited the down-regulation of E-cadherin expression and the up-regulation of α-smooth muscle actin (α-SMA) in primary mouse alveolar epithelial cells (MAECs) and A549 cell lines. Additionally, MTX-induced A549 cells exhibited an EMT-like phenotype accompanied by the elevation of the expression of interleukin-6 (IL-6) and transforming growth factor (TGF)-β1, as well as an enhancement of migration. All of these findings suggest that MTX-induced pulmonary fibrosis occurs via EMT.</abstract><cop>Japan</cop><pub>The Japanese Society of Toxicology</pub><pmid>24646714</pmid><doi>10.2131/jts.39.319</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0388-1350 |
ispartof | The Journal of Toxicological Sciences, 2014/04/01, Vol.39(2), pp.319-330 |
issn | 0388-1350 1880-3989 |
language | eng |
recordid | cdi_proquest_journals_1512807316 |
source | Free Full-Text Journals in Chemistry |
subjects | Actins - metabolism Alveolar epithelial cell Animals Cadherins - metabolism Cell Proliferation - drug effects Down-Regulation Epithelial Cells - drug effects Epithelial Cells - metabolism Epithelial Cells - pathology Epithelial mesenchymal transition Epithelial-Mesenchymal Transition - drug effects Epithelial-Mesenchymal Transition - genetics Humans Interleukin-6 - metabolism Methotrexate Methotrexate - adverse effects Mice Myofibroblasts - cytology Myofibroblasts - drug effects Myofibroblasts - pathology Pulmonary Alveoli - cytology Pulmonary Fibrosis - genetics Pulmonary Fibrosis - physiopathology Pulmonary toxicity Transforming Growth Factor beta1 - metabolism Tumor Cells, Cultured Up-Regulation Vimentin - metabolism |
title | Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A36%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20epithelial-mesenchymal%20transition%20in%20methotrexate-induced%20pulmonary%20fibrosis&rft.jtitle=Journal%20of%20toxicological%20sciences&rft.au=Ohbayashi,%20Masayuki&rft.date=2014-04-01&rft.volume=39&rft.issue=2&rft.spage=319&rft.epage=330&rft.pages=319-330&rft.issn=0388-1350&rft.eissn=1880-3989&rft_id=info:doi/10.2131/jts.39.319&rft_dat=%3Cproquest_cross%3E3266892261%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c590t-9b46780d3e5ed2f13fddaa3572ff65eb9b618a72b12083732d91e5d363f2e3313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1512807316&rft_id=info:pmid/24646714&rfr_iscdi=true |